MA29246B1 - Derives de dihydroimidazothiazole - Google Patents

Derives de dihydroimidazothiazole

Info

Publication number
MA29246B1
MA29246B1 MA30130A MA30130A MA29246B1 MA 29246 B1 MA29246 B1 MA 29246B1 MA 30130 A MA30130 A MA 30130A MA 30130 A MA30130 A MA 30130A MA 29246 B1 MA29246 B1 MA 29246B1
Authority
MA
Morocco
Prior art keywords
dihydroimidazothiazole
derivatives
recapture
noradrenaline
obesity
Prior art date
Application number
MA30130A
Other languages
English (en)
Inventor
Oscar Barba
Graham John Dawson
Thomas Martin Krulle
Robert John Rowley
Donald Smyth
Gerard Hugh Thomas
Original Assignee
Prosidion Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prosidion Ltd filed Critical Prosidion Ltd
Publication of MA29246B1 publication Critical patent/MA29246B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

L'INVENTION CONCERNE DES COMPOSÉS DE LA FORMULE (I), OU DES SELS PHARMACEUTIQUEMENT ACCEPTABLES DE CEUX-CI, QUI PRÉSENTENT UN AGONISME 5-HT1A, OUTRE L'INHIBITION DE LA RECAPTURE DE LA NORADRÉNALINE ET ÉVENTUELLEMENT L'INHIBITION DE LA RECAPTURE DE 5-HT, ET QUI SONT UTILISÉS DANS LE TRAITEMENT DE L'OBÉSITÉ.
MA30130A 2005-02-08 2007-08-08 Derives de dihydroimidazothiazole MA29246B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65090605P 2005-02-08 2005-02-08
US68436905P 2005-05-25 2005-05-25
US76166606P 2006-01-24 2006-01-24

Publications (1)

Publication Number Publication Date
MA29246B1 true MA29246B1 (fr) 2008-02-01

Family

ID=36654712

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30130A MA29246B1 (fr) 2005-02-08 2007-08-08 Derives de dihydroimidazothiazole

Country Status (16)

Country Link
US (1) US20090221645A1 (fr)
EP (1) EP1851232A2 (fr)
JP (1) JP2008530077A (fr)
KR (1) KR20070107116A (fr)
AR (1) AR053125A1 (fr)
AU (1) AU2006212038A1 (fr)
BR (1) BRPI0606881A2 (fr)
CA (1) CA2597288A1 (fr)
EA (1) EA012374B1 (fr)
IL (1) IL184996A0 (fr)
MA (1) MA29246B1 (fr)
MX (1) MX2007009526A (fr)
NO (1) NO20073941L (fr)
NZ (1) NZ561006A (fr)
TW (1) TW200639177A (fr)
WO (1) WO2006085118A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1923062A1 (fr) * 2006-11-16 2008-05-21 sanofi-aventis Imidazo[2,1-b]thiazoles et leur utilisation comme agent pharmaceutique
GB0916608D0 (en) 2009-09-22 2009-11-04 Angeletti P Ist Richerche Bio Therapeutic compounds
EP2766349B1 (fr) 2011-03-08 2016-06-01 Sanofi Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation
EP2683704B1 (fr) 2011-03-08 2014-12-17 Sanofi Dérivés oxathiazine ramifiés, procédé pour leur préparation, utilisation en tant que médicament, agents pharmaceutiques contenant ces dérivés et leur utilisation
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2567959B1 (fr) 2011-09-12 2014-04-16 Sanofi Dérivés d'amide d'acide 6-(4-hydroxy-phényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
US10421764B2 (en) * 2015-04-24 2019-09-24 H. Lee Moffitt Cancer Center And Research Institute, Inc. Mutant KRas inhibitors
CN109562113A (zh) 2016-05-10 2019-04-02 C4医药公司 用于靶蛋白降解的螺环降解决定子体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1488314A (fr) * 1966-04-25 1967-07-13 Chimetron Sarl Imidazothiazolyl-benzimidazoles
CH507982A (de) * 1968-05-15 1971-05-31 Sandoz Ag Verfahren zur Herstellung von 2-Chloräthyl-3-phenyl-5, 6-dihydroimidazo(2,1-b)thiazolen bzw. -6,7-dihydro-5H-thiazolo(3,2-a)pyrimidinen
CH513918A (de) * 1968-07-31 1971-10-15 Sandoz Ag Verfahren zur Herstellung von 2-n-Alkyl-3-phenyl-6,7-dihydro-5H-thiazolo(3,2-a)pyrimidinen bzw. 2-n-Alkyl-3-phenyl-5,6-dihydroimidazo(2,1-b)thiazolen
US3671533A (en) * 1970-01-26 1972-06-20 Sandoz Ag 2,3,5,6-TETRAHYDROIMIDAZO{8 2,1-b{9 THIAZOLES
US4041167A (en) * 1976-01-19 1977-08-09 Diamond Shamrock Corporation Antiinflammatory imidazothiazoles
JPS52106893A (en) * 1976-01-19 1977-09-07 Diamond Shamrock Corp Antiiinflammation imidazothiazole and thiazolopyrimidine
FR2643903A1 (fr) * 1989-03-03 1990-09-07 Union Pharma Scient Appl Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux

Also Published As

Publication number Publication date
NO20073941L (no) 2007-11-05
CA2597288A1 (fr) 2006-08-17
US20090221645A1 (en) 2009-09-03
WO2006085118A3 (fr) 2006-10-19
IL184996A0 (en) 2007-12-03
AR053125A1 (es) 2007-04-25
BRPI0606881A2 (pt) 2009-07-21
NZ561006A (en) 2010-06-25
KR20070107116A (ko) 2007-11-06
AU2006212038A1 (en) 2006-08-17
EP1851232A2 (fr) 2007-11-07
EA200701676A1 (ru) 2008-02-28
WO2006085118A2 (fr) 2006-08-17
EA012374B1 (ru) 2009-10-30
MX2007009526A (es) 2007-09-26
JP2008530077A (ja) 2008-08-07
TW200639177A (en) 2006-11-16

Similar Documents

Publication Publication Date Title
MA29246B1 (fr) Derives de dihydroimidazothiazole
MY134783A (en) Rho-kinase inhibitors
UY29927A1 (es) Derivados sustituidos de la 5-fenil-2-tioxo-imidazolin-4-ona y de la 5-fenil-2-amino-imidazolidin-4-ona y sus sales, composiciones y aplicaciones
DE60318177D1 (de) Rho-kinase inhibitoren
GEP20105073B (en) Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i
MA31084B1 (fr) Derives de piperidine agonistes de gpcr
WO2002076977A3 (fr) Inhibiteurs de rho-kinase
MA35643B1 (fr) Inhibiteur de cetp d'oxazolidinone bicyclique condensée
MA31906B1 (fr) Inhibiteurs de la replication du virus de limmunodeficience humaine
ATE368031T1 (de) Neue gamma secretase inhibitoren
NO20070247L (no) Amino-5,5-difenylimidazolonderivater for inhibisjon av beta-sekretase
EA200601686A1 (ru) Замещенные производные морфолина и тиоморфолина
CY1108252T1 (el) Χρηση παραγωγων μεθυλενο αμιδης στις καρδιαγγειακες διαταραχες
DE60312017D1 (de) Sulfonderivate zur hemmung von gamma-secretase
UY29919A1 (es) Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones
NO20075384L (no) Tiadiazolsubstituerte kumarinderivater og deres anvendelse som leukotrienbiosynteseinhibitorer.
MA30006B1 (fr) Composes anti-hypercholesterolemiques
NO20054083L (no) Nye sammenkoblede triazoloner og deres anvendelse
EA200702680A1 (ru) Масляный суспензионный концентрат
EA200600071A1 (ru) Производные n-фенилпиперазина и способы профилактики или лечения заболеваний, связанных с 5ht-рецептором
DK1373220T3 (da) Benzimidazoler, som er nyttige ved behandling af seksuel dysfunktion
NO20034301L (no) Cyano-substituerte dihydropyrimidin forbindelser
DE60325377D1 (de) Motilidverbindungen
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
TNSN07355A1 (fr) Derives d'aryl-1,4-pyrazine substitues